At Vistica Lifesciences, innovation meets precision in the form of cutting-edge injectable therapies designed to deliver results when they matter most. Our portfolio is trusted by healthcare professionals for its efficacy, safety, and consistent performance across critical care settings.

🔬 Here’s a closer look at Vistica’s Top 5 Injectable Products, each meticulously developed to serve a specific therapeutic need.

1️⃣ CASPOVIZ-50

(Caspofungin Acetate for Injection 50 mg)

🦠 CASPOVIZ-50 is an antifungal injectable used in the treatment of serious fungal infections such as invasive candidiasis and aspergillosis. Caspofungin works by inhibiting the synthesis of β-(1,3)-D-glucan, a critical component of the fungal cell wall.

⭐ Key Features:

  • 🛡️ Broad-spectrum antifungal coverage

  • 🧬 Ideal for hospitalized patients with compromised immunity

  • 💉 Administered via IV under professional supervision


2️⃣ CASPOVIZ-70

(Caspofungin Acetate for Injection 70 mg)
🚨 For cases that demand a higher loading dose, CASPOVIZ-70 delivers a powerful first-day antifungal defense. It’s particularly effective in critically ill patients and serves as a frontline therapy in ICU settings.

⭐ Key Features:

  • 🔄 Recommended as a loading dose in invasive fungal infections

  • 🧪 Supports early and aggressive antifungal intervention

  • ✅ Effective in both empirical and confirmed infections


3️⃣ CEREBOVIZ

(Cerebroprotein Hydrolysate for Injection 60 mg)
🧠 CEREBOVIZ is a neurotrophic agent designed to aid in neurorehabilitation. It is often prescribed for stroke recovery, traumatic brain injuries, and other neurodegenerative conditions. Cerebroprotein hydrolysate helps improve neuronal repair, cognitive function, and overall neurological outcomes.

⭐ Key Features:

  • 🌱 Promotes neuroregeneration and cognitive recovery

  • 🏥 Ideal for acute neuro care units & rehabilitation centers

  • 📊 Backed by clinical data for neuroprotective effects


4️⃣ ENOXAVIZ-40

(Enoxaparin Sodium Injection – Low Molecular Weight Heparin)
🩸 ENOXAVIZ-40 is used in the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism, and acute coronary syndromes. As a low molecular weight heparin (LMWH), it offers predictable anticoagulant effects with a lower risk of bleeding.

⭐ Key Features:

  • 🕒 Once-daily dosing for prophylactic use

  • ⚕️ High safety profile in surgical and post-operative settings

  • 💼 Convenient pre-filled syringe presentation


5️⃣ ENOXAVIZ-60

(Enoxaparin Sodium Injection – Low Molecular Weight Heparin)
❤️ ENOXAVIZ-60 provides a higher dose option for therapeutic anticoagulation, commonly used in treatment protocols for active thrombosis and in cardiology units for managing unstable angina and myocardial infarction.

⭐ Key Features:

  • 💪 Effective for full anticoagulation protocols

  • 🫀 Widely used in cardiology and emergency care

  • 📉 Reliable pharmacokinetics, reduced need for lab monitoring

🌐 Why Choose Vistica Injectables?

At Vistica Lifesciences, we are committed to producing injectables that meet global standards of purity, stability, and bioavailability. Our products are manufactured in GMP-compliant facilities and undergo rigorous quality control to ensure every dose delivers on its therapeutic promise.

💡 Whether in critical care, infectious disease, neurology, or cardiology, Vistica’s injectables are Formulated for Impact—because in medicine, precision isn’t optional-it’s essential.

You May Also Like:
👉 From Quality to Care: 6 Reasons to Choose Vistica Pharma

Product Enquiry